What is Merit Medical Systems, Inc.'s (MMSI) StockRank?

MoatMap's StockRank for Merit Medical Systems, Inc. (MMSI) is 79/100, with a Buy signal. This is a composite score combining Quality (66), Value (44), and Momentum (64) factor ranks across MoatMap's 20,000+ stock universe.

Does Merit Medical Systems, Inc. have an economic moat?

Merit Medical Systems, Inc. (MMSI) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Merit Medical Systems, Inc. a buy, hold, or sell?

MoatMap's current signal for Merit Medical Systems, Inc. (MMSI) is Buy, based on a StockRank of 79/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Merit Medical Systems, Inc. in?

Merit Medical Systems, Inc. (MMSI) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

MMSI

BUY

Merit Medical Systems, Inc. · Healthcare · United States · $4.4B · Avg Vol: $60M/d

StockRank

Get insider-trade alerts

P/E (TTM)

32.0x

ROE

9.1%

D/E

0.5x

Dividend %

—

COMPANY DESCRIPTION

Merit Medical Systems develops, manufactures, and distributes disposable medical devices for interventional cardiology, radiology, oncology, and endoscopy. The company maintains a strong global presence and diverse product portfolio in specialized medical device markets. It serves as a key supplier for hospitals and clinics worldwide, focusing on niche interventional and diagnostic device categories.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	1.2B	1.3B	1.4B	1.5B	9.6%	1.5B	1.6B	1.7B	6.5%
EPS	1.31	1.64	2.07	2.17	18.3%	2.35	2.31	2.49	7.2%
Shares	57.3M	57.9M	58.7M	59.4M	+3.7%	59.7M	—	—	—
Debt	268.8M	891.4M	794.7M	821.6M	45.1%	821.6M	—	—	—
Equity	1.1B	1.2B	1.4B	1.6B	11.5%	—	—	—	—
Op CF	114.3M	145.2M	220.8M	297.4M	37.5%	297.5M	—	—	—
Inv CF	-57.4M	-175.3M	-368.7M	-247.4M	—	—	—	—	—
Fin CF	-60.3M	559.3M	-60.0M	16.0M	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+14.4%

SMA 50SMA 200

$76.10

RSI (14)

60.9

52W High

$94.75

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

8.1%68.1

ROE

9.1%70.3

GP/Assets

28.0%63.0

Op. Margin

11.5%69.9

FCF/Assets

6.6%76.5

Piotroski

783.4

Int. Cover

7.5x57.4

D/E Ratio

0.51x30.1

Current Ratio

5.08x71.2

Value

P/E (TTM)

32.0x35.7

EV/EBITDA

15.0x44.6

P/FCF

24.9x49.4

P/B

2.8x47.8

P/S

2.9x57.8

Div Yield

—N/A

Momentum

52W High %

80%70.9

RS 6M

-15%54.0

SMA 50/200

0.90x40.0

EPS Rev 4W

+0.1%76.3

EPS Rev 12W

+0.3%61.2

EPS Improve

+87%70.0

Q Growth

36%70.8

FUNDAMENTALS

Market Cap

$4.4B

P/E (Forward)

17.1x

Gross Margin

48.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MMSI are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
MMSI	Merit Medical Systems, Inc.(you)	$4.4B	79	BUY
ICUI	ICU Medical, Inc.	$3.9B	83	STRONG BUY
NVST	Envista Holdings Corporation	$4.3B	90	STRONG BUY
TFX	Teleflex Incorporated	$5.8B	69	BUY
XRAY	DENTSPLY SIRONA Inc.	$2.6B	74	BUY
LMAT	LeMaitre Vascular, Inc.	$2.2B	76	BUY
ATR	AptarGroup, Inc.	$8.4B	74	BUY
SOLV	Solventum Corporation	$13.5B	80	BUY
AVTR	Avantor, Inc.	$7.8B	64	HOLD
BAX	Baxter International Inc.	$11.6B	71	BUY

Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.6%